miR-182-5p and miR-183-5p Act as GDNF Mimics in Dopaminergic Midbrain Neurons
Parkinson’s disease (PD) is the second-most-frequent neurodegenerative disorder worldwide. One major hallmark of PD is the degeneration of dopaminergic (DA) neurons in the substantia nigra. Glial cell line-derived neurotrophic factor (GDNF) potently increases DA neuron survival in models of PD; howe...
Main Authors: | Anna-Elisa Roser, Lucas Caldi Gomes, Rashi Halder, Gaurav Jain, Fabian Maass, Lars Tönges, Lars Tatenhorst, Mathias Bähr, André Fischer, Paul Lingor |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2018-06-01
|
Series: | Molecular Therapy: Nucleic Acids |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2162253118300064 |
Similar Items
-
Clinical Significance of miR-183-3p and miR-182-5p in NSCLC and Their Correlation
by: Zhang T, et al.
Published: (2021-04-01) -
Response of aged parkinsonian monkeys to in vivo gene transfer of GDNF
by: M.E. Emborg, et al.
Published: (2009-11-01) -
miR-182 and miR-183 Promote Cell Proliferation and Invasion by Targeting FOXO1 in Mesothelioma
by: Rui Suzuki, et al.
Published: (2018-10-01) -
Circulating miR-30a-5p and miR-182-5p in Prediabetes and Screen-Detected Diabetes Mellitus
by: Weale CJ, et al.
Published: (2020-12-01) -
A mouse model of miR-96, miR-182 and miR-183 misexpression implicates miRNAs in cochlear cell fate and homeostasis
by: Michael D. Weston, et al.
Published: (2018-02-01)